Home > Healthcare > Medical Devices > Diagnostic Devices > Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market Share

Report ID: GMI5597
Published Date: May 2023
Report Format: PDF

Download Free Sample

Infectious Disease Diagnostics Market Share

Abbott Laboratories
BioMerieus SA
Becton Dickinson and Company
Danaher Corporation
Bio-Rad Laboratories
F Hoffman-La Roche
Hologic Inc
Qiagen Inc
Siemens Healthineers,
Thermo Fisher Scientific Inc

are some of the leading infectious disease diagnostics industry market participants worldwide. These firms are actively adopting various strategies to boost their revenue sales.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for Infectious disease diagnostics was USD 24 billion in 2022 and will exhibit more than 5.5% CAGR from 2023-2032 due to the increasing preference for point-of-care diagnostic testing.

Respiratory disease applications will record 6% CAGR from 2023-2032 owing to the significant rise in the number of pathogens that cause respiratory infections include bacteria, viruses, fungi, and parasites.

North America infectious disease diagnostics market is estimated to exceed USD 17 billion by 2032 due to the surging frequency of infectious diseases and the scaling deployment of cutting-edge diagnostic technologies.

Abbott Laboratories, BioMerieus SA, Becton Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, F Hoffman-La Roche, Hologic Inc., Qiagen Inc., Siemens Healthineers, and Thermo Fisher Scientific Inc. are some infectious disease diagnostic companies. ?